Restructuring - Additional Information (Details) $ in Thousands |
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 03, 2025
USD ($)
|
Apr. 14, 2025
USD ($)
Positions
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2024
USD ($)
|
|
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring Charges | $ 11,938 | ||||
Impairment on lab equipment held-for-sale | $ 3,000 | 2,975 | $ 0 | ||
Write-offs prepayments for services related to our clinical and pre-clinical programs | 2,500 | ||||
Remaining liabilities related to restructuring | $ 7,300 | 7,300 | |||
Contract Termination Costs | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring Charges | $ 2,500 | $ 2,481 | |||
Discontinue of Clinical Development | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Number of positions reduced | Positions | 104 | ||||
Percentage of positions reduced | 90.00% | ||||
Discontinue of Clinical Development | Severance Payments and Employee Benefit Costs | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring expected cost | $ 9,500 |
X | ||||||||||
- Definition Write-offs prepayments for services related to our clinical and pre-clinical programs. No definition available.
|
X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount expected to be recognized in earnings for the specified restructuring cost. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of expected cost remaining for the specified restructuring cost. No definition available.
|
X | ||||||||||
- Definition The number of positions eliminated during the period as a result of restructuring activities. No definition available.
|
X | ||||||||||
- Definition The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s). No definition available.
|
X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|